159 related articles for article (PubMed ID: 7950902)
1. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
2. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
Gallicchio VS; Hughes NK
Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625
[TBL] [Abstract][Full Text] [Related]
3. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
Gallicchio VS; Hughes NK
Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood.
Zauli G; Vitale L; Brunelli MA; Bagnara GP
Exp Hematol; 1992 Aug; 20(7):850-4. PubMed ID: 1378407
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
7. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin 6.
Quesenberry PJ; McGrath HE; Williams ME; Robinson BE; Deacon DH; Clark S; Urdal D; McNiece IK
Exp Hematol; 1991 Jan; 19(1):35-41. PubMed ID: 1703492
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow natural suppressor cells inhibit the growth of myeloid progenitor cells and the synthesis of colony-stimulating factors.
Moore SC; Theus SA; Barnett JB; Soderberg LS
Exp Hematol; 1992 Nov; 20(10):1178-83. PubMed ID: 1426097
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia.
Estrov Z; Estey EH; Andreeff M; Talpaz M; Kurzrock R; Reading CL; Deisseroth AB; Gutterman JU
Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen.
Sugiura K; Ikehara S; Inaba M; Haraguchi S; Ogata H; Sardiña EE; Sugawara M; Ohta Y; Good RA
Exp Hematol; 1992 Feb; 20(2):256-63. PubMed ID: 1531958
[TBL] [Abstract][Full Text] [Related]
11. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
[TBL] [Abstract][Full Text] [Related]
12. High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells.
Patrone F; Ballestrero A; Balleari E; Bogliolo F; Brema F; Ferrando F; Ghio R; Timitilli S
Haematologica; 1992; 77(6):457-62. PubMed ID: 1289182
[TBL] [Abstract][Full Text] [Related]
13. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
de Haan G; Loeffler M; Nijhof W
Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
[TBL] [Abstract][Full Text] [Related]
15. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF.
Pojda Z; Molineux G; Dexter TM
Exp Hematol; 1990 Jan; 18(1):27-31. PubMed ID: 1688807
[TBL] [Abstract][Full Text] [Related]
16. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells.
Hestdal K; Ruscetti FW; Ihle JN; Jacobsen SE; Dubois CM; Kopp WC; Longo DL; Keller JR
J Immunol; 1991 Jul; 147(1):22-8. PubMed ID: 1711076
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo effects of MDP-Lys(L18) on mouse megakaryocyte progenitor cells (CFU-Meg).
Komiya I; Kuriya S; Akahane K; Nomura T
Exp Hematol; 1992 May; 20(4):517-22. PubMed ID: 1568468
[TBL] [Abstract][Full Text] [Related]
18. Specificity of heme for hemopoietic recovery from AZT toxicity.
Loewy G; Cook P; Ahmed T; Lutton JD; Nishimura M; Distenfeld A; Levere RD; Abraham NG
Hematol Pathol; 1992; 6(2):79-85. PubMed ID: 1607343
[TBL] [Abstract][Full Text] [Related]
19. Effects in vivo of recombinant human inhibin on myelopoiesis in mice.
Hangoc G; Carow CE; Schwall R; Mason AJ; Broxmeyer HE
Exp Hematol; 1992 Nov; 20(10):1243-6. PubMed ID: 1426104
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle status of murine megakaryocyte and granulocyte-macrophage colony-forming cells in bone marrow and spleen.
Cen D; Levin J
Exp Hematol; 1992 Oct; 20(9):1094-100. PubMed ID: 1468543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
